Search Results - "Farahmand, Leila"

Refine Results
  1. 1

    Breast cancer: Biology, biomarkers, and treatments by Barzaman, Khadijeh, Karami, Jafar, Zarei, Zeinab, Hosseinzadeh, Aysooda, Kazemi, Mohammad Hossein, Moradi-Kalbolandi, Shima, Safari, Elahe, Farahmand, Leila

    Published in International immunopharmacology (01-07-2020)
    “…•BCSCs are the most critical cells leading to chemo and radio-resistance in tumor therapy.•Signaling pathways/metabolic components in BCSC could be targeted as…”
    Get full text
    Journal Article
  2. 2

    Triple-negative breast cancer: understanding Wnt signaling in drug resistance by Merikhian, Parnaz, Eisavand, Mohammad Reza, Farahmand, Leila

    Published in Cancer cell international (10-08-2021)
    “…Abstract Triple-negative breast cancer (TNBC) is not as prevalent as hormone receptor or HER2-positive breast cancers and all receptor tests come back…”
    Get full text
    Journal Article
  3. 3

    Matrix stiffening and acquired resistance to chemotherapy: concepts and clinical significance by Darvishi, Behrad, Eisavand, Mohammad Reza, Majidzadeh-A, Keivan, Farahmand, Leila

    Published in British journal of cancer (18-05-2022)
    “…Extracellular matrix (ECM) refers to the non-cellular components of the tumour microenvironment, fundamentally providing a supportive scaffold for cellular…”
    Get full text
    Journal Article
  4. 4

    Challenges facing antiangiogenesis therapy: The significant role of hypoxia‐inducible factor and MET in development of resistance to anti‐vascular endothelial growth factor‐targeted therapies by Mahdi, Ali, Darvishi, Behrad, Majidzadeh‐A, Keivan, Salehi, Malihe, Farahmand, Leila

    Published in Journal of cellular physiology (01-05-2019)
    “…It is now fully recognized that along with multiple physiological functions, angiogenesis is also involved in the fundamental process and pathobiology of…”
    Get full text
    Journal Article
  5. 5

    Crosstalk between MUC1 and VEGF in angiogenesis and metastasis: a review highlighting roles of the MUC1 with an emphasis on metastatic and angiogenic signaling by Khodabakhsh, Farnaz, Merikhian, Parnaz, Eisavand, Mohammad Reza, Farahmand, Leila

    Published in Cancer cell international (09-04-2021)
    “…VEGF and its receptor family (VEGFR) members have unique signaling transduction system that play significant roles in most pathological processes, such as…”
    Get full text
    Journal Article
  6. 6

    Anticancer potentiality and mode of action of low-carbohydrate proteins and peptides from mushrooms by Rezvani, Vala, Pourianfar, Hamid R., Mohammadnejad, Safoora, Madjid Ansari, Alireza, Farahmand, Leila

    Published in Applied microbiology and biotechnology (01-08-2020)
    “…Severe side effects of chemotherapy as well as drug resistance highlight the ongoing need to discover novel natural bioactive compounds with anticancer…”
    Get full text
    Journal Article
  7. 7

    The Role of Mucosal Immunity and Recombinant Probiotics in SARS-CoV2 Vaccine Development by Moradi-kalbolandi, Shima, Majidzadeh-A, Keyvan, Abdolvahab, Mohadeseh Haji, Jalili, Neda, Farahmand, Leila

    Published in Probiotics and antimicrobial proteins (01-10-2021)
    “…Severe acute respiratory syndrome coronavirus 2 (SARS-CoV2), causing the 2019 novel coronavirus disease (COVID-19), was introduced by WHO (World Health…”
    Get full text
    Journal Article
  8. 8

    Stimuli-Responsive Mesoporous Silica NPs as Non-viral Dual siRNA/Chemotherapy Carriers for Triple Negative Breast Cancer by Darvishi, Behrad, Farahmand, Leila, Majidzadeh-A, Keivan

    Published in Molecular therapy. Nucleic acids (16-06-2017)
    “…Triple negative breast cancer (TNBC) is the most aggressive and lethal subtype of breast cancer. It is associated with a very poor prognosis and intrinsically…”
    Get full text
    Journal Article
  9. 9

    The antiproliferative effects of cold atmospheric plasma‐activated media on different cancer cell lines, the implication of ozone as a possible underlying mechanism by Mokhtari, Hesam, Farahmand, Leila, Yaserian, Kiomars, Jalili, Neda, Majidzadeh‐A, Keivan

    Published in Journal of cellular physiology (01-05-2019)
    “…Recent studies have proven several promising anticancer activities for cold atmospheric plasma (CAP) against a wide range of cancer cells in vitro. Recently,…”
    Get full text
    Journal Article
  10. 10

    MUC1 is a potential target to overcome trastuzumab resistance in breast cancer therapy by Hosseinzadeh, Aysooda, Merikhian, Parnaz, Naseri, Nazanin, Eisavand, Mohammad Reza, Farahmand, Leila

    Published in Cancer cell international (05-03-2022)
    “…Although resistance is its major obstacle in cancer therapy, trastuzumab is the most successful agent in treating epidermal growth factor receptor 2 positive…”
    Get full text
    Journal Article
  11. 11

    Monoclonal antibody‐based therapeutics, targeting the epidermal growth factor receptor family: from herceptin to Pan HER by Moradi‐Kalbolandi, Shima, Hosseinzade, Aysooda, Salehi, Malihe, Merikhian, Parnaz, Farahmand, Leila

    Published in Journal of pharmacy and pharmacology (01-07-2018)
    “…Objectives Monoclonal antibody‐based of cancer therapy has been considered as one of the most successful therapeutic strategies for both haematologic…”
    Get full text
    Journal Article
  12. 12

    NF-κB as the main node of resistance to receptor tyrosine kinase inhibitors in triple-negative breast cancer by Darvishi, Behrad, Farahmand, Leila, Eslami-S, Zahra, Majidzadeh-A, Keivan

    Published in Tumor Biology (01-06-2017)
    “…Graphical abstract Although accounting for merely a minute portion of diagnosed breast cancers, disproportionate number of deaths and associated low survival…”
    Get full text
    Book Review Journal Article
  13. 13

    Suppression of chronic inflammation with engineered nanomaterials delivering nuclear factor κB transcription factor decoy oligodeoxynucleotides by Farahmand, Leila, Darvishi, Behrad, Majidzadeh-A, Keivan

    Published in Drug delivery (01-11-2017)
    “…As a prototypical pro-inflammatory transcription factor, constitutive activation of NF-κB signaling pathway has been reported in several chronic inflammatory…”
    Get full text
    Journal Article
  14. 14

    Anti-MUC1 nanobody conjugated by chitosan nanoparticle with enhancement of anti-proliferation activity in breast cancer cell lines by Khodabakhsh, Farnaz, Shokri, Shima, Jalili, Neda, Moradi-Kalbolandi, Shima, Dashtestani, Fariba, Farahmand, Leila

    Published in Chemical papers (01-04-2023)
    “…Breast cancer is one of the most common cancers among women. Antibodies are used to deliver a specific drug to the tumor area. Nanotechnology and monoclonal…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Anti-cancer therapeutic strategies based on HGF/MET, EpCAM, and tumor-stromal cross talk by Barzaman, Khadijeh, Vafaei, Rana, Samadi, Mitra, Kazemi, Mohammad Hossein, Hosseinzadeh, Aysooda, Merikhian, Parnaz, Moradi-Kalbolandi, Shima, Eisavand, Mohammad Reza, Dinvari, Houra, Farahmand, Leila

    Published in Cancer cell international (19-08-2022)
    “…Abstract As an intelligent disease, tumors apply several pathways to evade the immune system. It can use alternative routes to bypass intracellular signaling…”
    Get full text
    Journal Article
  17. 17

    Synthesized Anti-HER2 Trastuzumab-MCC-DM1 Conjugate: An Evaluation of Efficacy and Cytotoxicity by Shafiee, Soodabeh, Mirzaei, Roya, Salehi, Malihe, Jalili, Neda, Taheri, Amir, Farahmand, Leila

    Published in Iranian journal of immunology (01-09-2023)
    “…Trastuzumab is a humanized monoclonal antibody that targets site-specifically human epidermal growth factor-2 receptor (HER2) cell surface antigen…”
    Get full text
    Journal Article
  18. 18

    MED1 may explain the interaction between receptor tyrosine kinases and ERα66 in the complicated network of Tamoxifen resistance by Mansouri, Sepideh, Naghavi-al-Hosseini, Fateme, Farahmand, Leila, Majidzadeh-A, Keivan

    Published in European journal of pharmacology (05-06-2017)
    “…According to the American Society of Clinical Oncology or ASCO's clinical practice guidelines, administration of Tamoxifen for hormone receptor positive…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Comparison of mucin-1 in human breast cancer and canine mammary gland tumor: a review study by Vafaei, Rana, Samadi, Mitra, Hosseinzadeh, Aysooda, Barzaman, Khadijeh, Esmailinejad, MohammadReza, Khaki, Zohreh, Farahmand, Leila

    Published in Cancer cell international (09-01-2022)
    “…Mucin-1 (MUC-1) is a transmembrane glycoprotein, which bears many similarities between dogs and humans. Since the existence of animal models is essential to…”
    Get full text
    Journal Article